Publication | Closed Access

Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia

Hematological MalignancyChromatinEpigenetics-modifying GeneMixed-phenotype Acute LeukemiaGeneticsAcute Myeloid LeukemiaClinical EpigeneticsCancer GeneticsMedicineRadiation OncologyEpigeneticsMyeloid Neoplasia